Use of health information technology in acute care settings is associated with modestly lower rates of adverse patient safety outcomes for inpatient and surgical care.
Changes in generic drug appearance occur often. Patients’ and pharmacists’ responses to those changes vary, with some patients stopping their medication or using it less.
Enrollment in a secondary disease prevention program can have a significant impact on statin adherence and subsequent clinical outcomes.
Accountable care organizations (ACOs) deliver a diverse array of home-based services, but many of the services are not reimbursed. ACOs may not expand these programs without strong evidence of cost savings.
Private negotiated facility fees at hospitals are on average double the ambulatory surgery center facility fees for common outpatient procedures.
In the 6 years following inpatient electronic health record (EHR) implementation, an average of 2.5 significant EHR changes per day were made for maintenance and improvement.
A partnership between JDRF and Janssen Pharmaceuticals seeks ways to intercept the disease before it progresses.
Proactive identification of cognitive impairment and compensatory destigmatized patient/familial psychoeducation regarding “forgetfulness” in hospitalized patients with congestive heart failure may reduce readmission rates substantially.
Moderate underreporting biases were found when patient responses to an interactive voice response system were compared with medical records in the STAR*D clinical trial.
Complex care is cross-sector and person-centered, and it could bend America’s healthcare cost curve. The Blueprint for Complex Care gives this new field a national framework.
The authors quantify the potential reduction in hospital costs from adopting best local practices in supply chain management and discharge planning within a major metropolitan market.
This study evaluates the ease of ordering high- and low-value clinical services in a national sample of electronic health records.
2018 was a landmark year for new drug approvals. However, patients’ access to these novel drugs varied by drug category and enrolled health plan.
The authors compared targeting strategies and characteristics of chronic disease care management programs delivered by primary care practices with one administered by a large health plan.